Skip to content
healthcare.dev

Hetlioz LQ

NDC 43068-304, tasimelteon, suspension, from Vanda Pharmaceuticals Inc..

Product NDC
43068-304
Status
Listed
Labeler
Vanda Pharmaceuticals Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214517
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43068-304 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TASIMELTEON4 mg/mL

Pharmacologic classes

Melatonin Receptor Agonist [EPC]; Melatonin Receptor Agonists [MoA]

Package NDCNDC-11Package
43068-304-02430680304021 BOTTLE in 1 CARTON (43068-304-02) / 48 mL in 1 BOTTLE
43068-304-06430680304061 BOTTLE in 1 CARTON (43068-304-06) / 158 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ca4a9b63-708e-49e9-8f9b-010625443b90

Use it

Look up 43068-304 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43068-304 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43068-304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.